Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches

A Kato, AT Peters, WW Stevens, RP Schleimer… - Allergy, 2022 - Wiley Online Library
Chronic rhinosinusitis (CRS) is a common clinical syndrome that produces significant
morbidity and costs to our health system. The study of CRS has progressed from an era …

The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps

P Gevaert, JK Han, SG Smith, AR Sousa… - International forum of …, 2022 - Wiley Online Library
Chronic rhinosinusitis with nasal polyps (CRSwNP) is generally associated with eosinophilic
tissue infiltration linked to type 2 inflammation and characterized by elevated levels of …

[HTML][HTML] Chronic rhinosinusitis with nasal polyps and asthma

TM Laidlaw, J Mullol, KM Woessner, N Amin… - The Journal of Allergy …, 2021 - Elsevier
Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) characterized by a type 2
immune signature often have severe and recurrent disease. Lower airway conditions such …

[HTML][HTML] Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count

C Bachert, AR Sousa, JK Han, RJ Schlosser… - Journal of Allergy and …, 2022 - Elsevier
Background In the Phase III SYNAPSE study, mepolizumab reduced nasal polyp (NP) size
and nasal obstruction in chronic rhinosinusitis with NP (CRSwNP). Objective To assess the …

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): in‐depth sinus surgery analysis

WJ Fokkens, J Mullol, D Kennedy, C Philpott, V Seccia… - Allergy, 2023 - Wiley Online Library
Background Patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) often
require repeat sinus surgery. Mepolizumab reduced the need for sinus surgery in the …

Prognostic and pharmacologic value of cystatin SN for chronic rhinosinusitis with nasal polyps

D Wu, B Yan, Y Wang, C Wang, L Zhang - Journal of Allergy and Clinical …, 2021 - Elsevier
Background Integrated care pathways improve the management of patients with chronic
rhinosinusitis with nasal polyps (CRSwNP). The application of integrated care pathways …

Prognostic factors for post-operative outcomes in chronic rhinosinusitis with nasal polyps: a systematic review

S Cai, H Lou, L Zhang - Expert Review of Clinical Immunology, 2023 - Taylor & Francis
Introduction Chronic rhinosinusitis with nasal polyps (CRSwNP) has a high recurrence rate
after surgery despite the availability of medical treatments. Multiple clinical and biological …

[HTML][HTML] Real-life effectiveness of mepolizumab in refractory chronic rhinosinusitis with nasal polyps

MS Domínguez-Sosa, MS Cabrera-Ramírez… - Biomedicines, 2023 - mdpi.com
The aim of this study was to evaluate the efficacy of mepolizumab in patients affected by
chronic rhinosinusitis with nasal polyps (CRSwNP) in real-life. A single-center retrospective …

[HTML][HTML] Sinonasal biomarkers defining type 2-high and type 2-low inflammation in chronic rhinosinusitis with nasal polyps

E De Corso, S Baroni, S Settimi, ME Onori… - Journal of Personalized …, 2022 - mdpi.com
The complex pathophysiology of chronic rhinosinusitis with nasal polyps (CRSwNP)
generates a spectrum of phenotypes with a wide variety of inflammatory states. We enrolled …

[HTML][HTML] Differential nasal swab cytology represents a valuable tool for therapy monitoring but not prediction of therapy response in chronic rhinosinusitis with nasal …

Z Danisman, M Linxweiler, JP Kühn… - Frontiers in …, 2023 - frontiersin.org
Introduction Chronic Rhinosinusitis with nasal polyps (CRSwNP) is a common chronic
disease with a high impact on patients' quality of life. If conservative and surgical guideline …